Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
06/05/2026
The South Korean won hit its highest level against the US dollar since February 27th.
Latest
1 m ago
Novo Nordisk: Sales of the weight loss drug Wegovy in the first quarter were DKK 18.235 billion, exceeding the market estimate of DKK 17.396 billion.
2 m ago
Novo Nordisk: WEGOVY sales in the first quarter amounted to 18.24 billion Danish kroner.
2 m ago
Novo Nordisk expects full-year adjusted sales to decline by 4% to 12% year-on-year, compared to the previous forecast of a 5% to 13% decline.
3 m ago
Novo Nordisk: The company raised its performance expectations for 2026 due to the expected increase in sales of GLP-1 products.
3 m ago
In the first quarter of 2026, Novo Nordisk's adjusted operating profit reached 32.858 billion Danish kroner.
See all latest
